Drug intelligence / Profile preview

cyproterone acetate + ethinylestradiol + metformin

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

A combination therapy used primarily for treating polycystic ovary syndrome (PCOS). This combination addresses multiple aspects of PCOS: - **Cyproterone acetate**: A steroidal antiandrogen that blocks androgen production in the ovaries, reducing hirsutism and acne - **Ethinylestradiol**: An estrogen that enhances cyproterone's effects by further reducing androgen levels and regularizing menstrual cycles - **Metformin**: An insulin sensitizer that improves metabolic parameters and may further suppress hyperandrogenemia Clinical studies show this combination provides better and faster decreases in testosterone levels and free androgen index compared to cyproterone acetate/ethinylestradiol alone, without deteriorating anthropometric indices or insulin sensitivity.

Brand names
Diane-35 + metformin
Other names
metformin + oral contraceptivemetformin + Diane-35metformin + CPA/EE
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)ER (Estrogen receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on cyproterone acetate + ethinylestradiol + metformin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyproterone acetate + ethinylestradiol + metformin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call